Aethlon Medical (AEMD) stock price, revenue, and financials

Aethlon Medical market cap is $6.7 m, and annual revenue was $149.63 k in FY 2018

$6.7 M

AEMD Mkt cap, 10-Jun-2019

$149.6 K

Aethlon Medical Revenue FY, 2018
Aethlon Medical Revenue growth (FY, 2017 - FY, 2018), %(62%)
Aethlon Medical Net income (FY, 2018)-5.7 M
Aethlon Medical EBIT (FY, 2018)-4.8 M
Aethlon Medical Cash, 31-Mar-20187 M
Aethlon Medical EV522.2 K

Aethlon Medical Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

762.4k886.6k392.1k149.6k

Revenue growth, %

16%(56%)(62%)

General and administrative expense

907.1k929.0k849.5k792.6k

Operating expense total

4.8m5.3m6.5m5.0m

EBIT

(4.0m)(4.4m)(6.1m)(4.8m)

EBIT margin, %

(524%)(495%)(1555%)(3229%)

Interest expense

452.3k573.8k558.2k376.9k

Net Income

(6.8m)(4.9m)(7.3m)(5.7m)

Aethlon Medical Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018

Cash

855.6k2.1m1.6m7.0m

Accounts Receivable

193.3k199.5k74.8k

Prepaid Expenses

73.1k53.3k37.6k181.4k

Current Assets

1.2m2.4m1.6m7.2m

PP&E

56.1k36.0k29.2k27.6k

Total Assets

1.4m2.5m1.7m7.4m

Accounts Payable

342.1k244.8k484.4k124.5k

Current Liabilities

574.0k526.6k611.8k478.0k

Long-term debt

155.2k500.1k519.2k841.2k

Non-Current Liabilities

155.2k500.1k519.2k841.2k

Total Debt

155.2k500.1k519.2k841.2k

Total Liabilities

729.2k1.0m1.1m1.3m

Common Stock

6.7k7.6k8.8k17.7k

Additional Paid-in Capital

82.2m88.0m94.4m105.6m

Retained Earnings

(81.6m)(86.5m)(93.8m)(99.5m)

Total Equity

651.4k1.5m595.4k6.0m

EPS

(1.2)(0.7)(0.9)(0.5)

Debt to Equity Ratio

0.9 x0.1 x

Debt to Assets Ratio

0.3 x0.1 x

Financial Leverage

2.1 x1.7 x2.9 x1.2 x

Aethlon Medical Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(7.0m)(5.0m)(7.3m)(5.7m)

Depreciation and Amortization

37.4k38.5k32.4k35.7k

Accounts Receivable

(98.2k)(6.1k)199.5k(74.8k)

Accounts Payable

(1.1m)(46.4k)322.1k(104.2k)

Cash From Operating Activities

(5.0m)(4.3m)(3.5m)(3.9m)

Purchases of PP&E

(9.3k)(16.4k)(24.8k)

Cash From Investing Activities

(9.3k)(16.4k)(24.8k)

Long-term Borrowings

(523.4k)

Cash From Financing Activities

4.7m5.6m3.0m9.3m

Net Change in Cash

(394.7k)1.3m(564.0k)5.4m

Aethlon Medical Ratios

USDY, 2018

EV/EBIT

0.2 x

EV/CFO

0.2 x

Revenue/Employee

24.9k

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.2 x

P/E Ratio

(0.6)